New proposal form February 2015
... Committee (D&TC) – the local D&TC will review the application; if considered appropriate they will forward to DMAG to consider the implications of inclusion across the Dorset healthcare community. It should be completed by a clinical working group making an application following discussion. Medi ...
... Committee (D&TC) – the local D&TC will review the application; if considered appropriate they will forward to DMAG to consider the implications of inclusion across the Dorset healthcare community. It should be completed by a clinical working group making an application following discussion. Medi ...
Protocol - Doncaster LMC
... increased to 10mg daily after this time if necessary Galantamine: As tablets or liquid initially 4mg bd with meals, continued for one month. The dose is then increased to a therapeutic dose of 8mg bd and then 12mg bd in selected patients if necessary. As modified release (Reminyl XL) 8mg mane after ...
... increased to 10mg daily after this time if necessary Galantamine: As tablets or liquid initially 4mg bd with meals, continued for one month. The dose is then increased to a therapeutic dose of 8mg bd and then 12mg bd in selected patients if necessary. As modified release (Reminyl XL) 8mg mane after ...
paperless tailored lower risk cost efficient
... Cancer is the most costly pathology in health systems and one that is on the rise due to: ...
... Cancer is the most costly pathology in health systems and one that is on the rise due to: ...
document - Herts Valleys CCG
... Ranibizumab and aflibercept for treating diabetic macular oedema (DMO), NICE TA274, February 2013 (rapid review of TA237) and TA346, July 2015 Only fully completed forms will be accepted for consideration The completed form must be sent by the hospital commissioning team to the High Cost Drugs Team ...
... Ranibizumab and aflibercept for treating diabetic macular oedema (DMO), NICE TA274, February 2013 (rapid review of TA237) and TA346, July 2015 Only fully completed forms will be accepted for consideration The completed form must be sent by the hospital commissioning team to the High Cost Drugs Team ...
Ranibizumab and aflibercept for Diabetic Macular Oedema TA274
... Ranibizumab and aflibercept for treating diabetic macular oedema (DMO), NICE TA274, February 2013 (rapid review of TA237) and TA346, July 2015 Only fully completed forms will be accepted for consideration The completed form must be sent by the hospital commissioning team to the High Cost Drugs Team ...
... Ranibizumab and aflibercept for treating diabetic macular oedema (DMO), NICE TA274, February 2013 (rapid review of TA237) and TA346, July 2015 Only fully completed forms will be accepted for consideration The completed form must be sent by the hospital commissioning team to the High Cost Drugs Team ...
9th July 2014 meeting minutes - Gateshead Health NHS Foundation
... Items circulated were: Gateshead CCG Q4 2013/14 Report Circulated for information. Concerns re increasing use of rosuvastatin and Omacor. This will be taken with up the appropriate prescribers Gateshead Primary Care Guidelines The highlighted guidelines are due for review and work is underway to ...
... Items circulated were: Gateshead CCG Q4 2013/14 Report Circulated for information. Concerns re increasing use of rosuvastatin and Omacor. This will be taken with up the appropriate prescribers Gateshead Primary Care Guidelines The highlighted guidelines are due for review and work is underway to ...
Recently Introduced Products
... Ozurdex consists of a specially designed drug delivery system that is injected into the eye by an ophthalmologist. The recommended dose is one implant into the affected eye, and retreatment may occur at an interval of approximately 6 months. Repeat doses are intended for patients who initially respo ...
... Ozurdex consists of a specially designed drug delivery system that is injected into the eye by an ophthalmologist. The recommended dose is one implant into the affected eye, and retreatment may occur at an interval of approximately 6 months. Repeat doses are intended for patients who initially respo ...
Letrozole - Wolverhampton Formulary
... Initiate treatment and provide at least 28 days’ supply. Discuss the benefits and side effects of treatment with the patient. Ask the GP whether he or she is willing to participate in shared care, and agree with the GP as to who will discuss the shared care arrangement with the patient. Supply GP wi ...
... Initiate treatment and provide at least 28 days’ supply. Discuss the benefits and side effects of treatment with the patient. Ask the GP whether he or she is willing to participate in shared care, and agree with the GP as to who will discuss the shared care arrangement with the patient. Supply GP wi ...
Autonomy Autonomy Autonomy? The Elements of Autonomy
... in circumstances when they are required y Selecting treatments with lower levels of side effect or fewer concerns for long‐term use f f l y Prescribing the minimum number of different medications y Simplifying dosage regime by selecting a different drug, or using a sustained release preparation t ...
... in circumstances when they are required y Selecting treatments with lower levels of side effect or fewer concerns for long‐term use f f l y Prescribing the minimum number of different medications y Simplifying dosage regime by selecting a different drug, or using a sustained release preparation t ...
IontoPatch - North Coast Medical
... IontoPatchi lets patients receive iontophoresis treatments without being attached to external batteries or wires. An ultra-thin, self-contained battery produces an electric current that carries drug molecules non-invasively across the skin to underlying tissue. IontoPatchu does not have buffering ag ...
... IontoPatchi lets patients receive iontophoresis treatments without being attached to external batteries or wires. An ultra-thin, self-contained battery produces an electric current that carries drug molecules non-invasively across the skin to underlying tissue. IontoPatchu does not have buffering ag ...
MORPHINE-INDUCED NEUROTOXICITY: POSSIBLE …
... • Improve the quality of mental health care by the application of existing knowledge. • Changes in clinical practices, services provided, and reimbursement methods would make a huge difference in the quality of care and outcomes of patients. • ? Greater use of clozapine and long-acting injectables • ...
... • Improve the quality of mental health care by the application of existing knowledge. • Changes in clinical practices, services provided, and reimbursement methods would make a huge difference in the quality of care and outcomes of patients. • ? Greater use of clozapine and long-acting injectables • ...
Drugs → brain structures AP MST Bipolar disorder NICE Diagnosis
... striatum by antipsychotics with high dopamine receptor affinity and in the cortex by antipsychotics with mixed serotonergic/dopaminergic profile ...
... striatum by antipsychotics with high dopamine receptor affinity and in the cortex by antipsychotics with mixed serotonergic/dopaminergic profile ...
Guidelines for Initiating Treatment With Denosumab
... Report any adverse events to the Medicines and Health Care Regulatory Agency (MHRA). Responsibilities of clinician prescribing on-going treatment ...
... Report any adverse events to the Medicines and Health Care Regulatory Agency (MHRA). Responsibilities of clinician prescribing on-going treatment ...
• The smallest effective dose of a laxative should be used, and this
... Fibre - high dietary fibre is effective in increasing stool weight, and reduces faecal transit time. A high-fibre diet, about 30 g per day, (e.g. high in fruit, vegetables, wholemeal bread, cereals, and grain foods) should be tried for at least one month before its effects on constipation are determ ...
... Fibre - high dietary fibre is effective in increasing stool weight, and reduces faecal transit time. A high-fibre diet, about 30 g per day, (e.g. high in fruit, vegetables, wholemeal bread, cereals, and grain foods) should be tried for at least one month before its effects on constipation are determ ...
3Ts Depression Treatment Pathway
... Switch to a different antidepressant SECOND LINE (see notes) Try an alternative SSRI e.g. sertraline or fluoxetine Mirtazapine – (If not already used - see first line treatment) Venlafaxine - less risk of discontinuation symptoms with MR formulation. 75mg dose acts as an SSRI so little benefit. BP s ...
... Switch to a different antidepressant SECOND LINE (see notes) Try an alternative SSRI e.g. sertraline or fluoxetine Mirtazapine – (If not already used - see first line treatment) Venlafaxine - less risk of discontinuation symptoms with MR formulation. 75mg dose acts as an SSRI so little benefit. BP s ...
When or if to re-start ACEI, ARB, diuretics and other antihypertensive
... b. If a patient is left off treatment (for instance, if clinic BP is <140/90 or home BP <130/85), further follow-up should be offered for at least 12 months, as it may take some time for blood pressure to return to previous levels after recovery from acute illness. 7. All of the above should be appl ...
... b. If a patient is left off treatment (for instance, if clinic BP is <140/90 or home BP <130/85), further follow-up should be offered for at least 12 months, as it may take some time for blood pressure to return to previous levels after recovery from acute illness. 7. All of the above should be appl ...
NICE TA 315. Shared Care available
... 4. People currently receiving treatment initiated within the NHS with canagliflozin that is not recommended for them by NICE in this guidance should be able to continue treatment until they and their NHS clinician consider it appropriate to stop. ...
... 4. People currently receiving treatment initiated within the NHS with canagliflozin that is not recommended for them by NICE in this guidance should be able to continue treatment until they and their NHS clinician consider it appropriate to stop. ...
7.3 Prazosin factsheet
... FOR INITIATION ONLY BY OR ON THE ADVICE OF A HOSPITAL SPECIALIST it would be important that a patient being considered for treatment with Prazosin for PTSD nightmares was also assessed within the Community Mental Health Team to identify psychiatric co-morbidities and to consider referral for appropr ...
... FOR INITIATION ONLY BY OR ON THE ADVICE OF A HOSPITAL SPECIALIST it would be important that a patient being considered for treatment with Prazosin for PTSD nightmares was also assessed within the Community Mental Health Team to identify psychiatric co-morbidities and to consider referral for appropr ...
Traffic Light Comment - West Suffolk Clinical Commissioning Group
... Reason for recommendation: In line with NICE guidance Type 2 diabetes in adults: management December 2015 and WSCCG Type 2 Diabetes Mellitus Adult Treatment Pathway March 2016, discussions at the Prescribing Workstream suggested an agreement with Dr. Clark’s comments and support for dulaglutide (Tru ...
... Reason for recommendation: In line with NICE guidance Type 2 diabetes in adults: management December 2015 and WSCCG Type 2 Diabetes Mellitus Adult Treatment Pathway March 2016, discussions at the Prescribing Workstream suggested an agreement with Dr. Clark’s comments and support for dulaglutide (Tru ...
Scottish Medicines Consortium follitropin alfa 150 IU/lutropin alfa 75
... This advice represents the view of the Scottish Medicines Consortium and was arrived at after evaluation of the evidence submitted by the company. It is provided to inform the considerations of Area Drug & Therapeutics Committees and NHS Boards in Scotland in determining medicines for local use or l ...
... This advice represents the view of the Scottish Medicines Consortium and was arrived at after evaluation of the evidence submitted by the company. It is provided to inform the considerations of Area Drug & Therapeutics Committees and NHS Boards in Scotland in determining medicines for local use or l ...
Omacor® capsules (post MI)
... dietary consumption of fish, fresh vegetables and olive oil, described by many as a ‘Mediterranean diet’ which may also have contributed to the beneficial effects and so transferability of the results to a Greater Manchester population are questionable. The group therefore concluded that a diet high ...
... dietary consumption of fish, fresh vegetables and olive oil, described by many as a ‘Mediterranean diet’ which may also have contributed to the beneficial effects and so transferability of the results to a Greater Manchester population are questionable. The group therefore concluded that a diet high ...
Denosumab (Prolia®) for osteoporosis
... The need to continue treatment with denosumab, as with all other anti-resorptive agents, should be reviewed after a maximum of 5 years. Review requires a re-evaluation of the patient’s fracture risk, normally including a repeat DXA scan. Atypical femoral fractures have been reported in association w ...
... The need to continue treatment with denosumab, as with all other anti-resorptive agents, should be reviewed after a maximum of 5 years. Review requires a re-evaluation of the patient’s fracture risk, normally including a repeat DXA scan. Atypical femoral fractures have been reported in association w ...
COGNITIVE MODEL OF EMOTIONAL DISTRESS
... March 2010 – February 2011 Dosulepin prescribed items March 2010 - February 2011 ...
... March 2010 – February 2011 Dosulepin prescribed items March 2010 - February 2011 ...